Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2

Izabela Sitkiewicz1, Michal J Nagiec, Paul Sumby

  • 1Center for Molecular and Translational Human Infectious Diseases Research, Methodist Hospital Research Institute, Houston, TX 77030, USA.

Insights

The acquisition of a specific bacteriophage significantly enhanced the virulence and spread of a Group A Streptococcus clone. This study identifies a key molecular event driving severe bacterial infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • The molecular mechanisms behind the emergence of new pathogen clones are not well understood.
  • A hypervirulent clone of serotype M3 Group A Streptococcus (GAS) emerged in the mid-1980s, potentially due to bacteriophage acquisition.
  • A secreted phospholipase A2 (SlaA) encoded by this bacteriophage is suspected to be a virulence factor, but this lacks experimental validation.

Purpose of the Study:

  • To experimentally investigate the role of SlaA in the virulence and pathogenesis of serotype M3 Group A Streptococcus.
  • To determine if SlaA contributes to bacterial adherence, host cell killing, and disease progression in animal models.

Main Methods:

  • Construction and characterization of an isogenic DeltaslaA mutant strain of serotype M3 GAS.
  • In vitro assays assessing bacterial adherence to and killing of human epithelial cells.
  • In vivo studies evaluating bacterial virulence in mouse models and colonization in a non-human primate model of pharyngitis.
  • Assessment of protective immunity through immunization with purified SlaA in mice.

Main Results:

  • The DeltaslaA mutant strain showed significantly reduced adherence to and killing of human epithelial cells compared to the wild-type strain.
  • The mutant strain exhibited decreased virulence in a mouse model and was attenuated in colonizing the pharynx in a monkey model.
  • Immunization with SlaA provided significant protection against invasive disease in mice.

Conclusions:

  • Transductional acquisition of the SlaA gene enhanced the spread and virulence of the serotype M3 GAS precursor strain.
  • SlaA is a crucial virulence factor contributing to the evolution and dissemination of this hypervirulent bacterial clone.
  • These findings elucidate a key molecular event responsible for the emergence of severe human infections caused by this specific GAS clone.

Related Concept Videos

Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...